Ascentage Pharma Group International appointed Dr. Faiçal Miyara as Chief Business Officer to lead global business development and Jim Ziegler as Chief Commercial Officer to head US commercialization efforts. Both executives report directly to Chairman and CEO Dr. Dajun Yang. The appointments aim to strengthen the company's global expansion strategy, build a dedicated US commercial organization, and accelerate the execution of its pipeline for hematologic malignancies. Ascentage Pharma is an integrated biopharmaceutical company engaged in the discovery, development, and commercialization of novel cancer therapies.
